AAAAAA

   
Results: 1-17 |
Results: 17

Authors: STRAUS DJ HUANG J TESTA MA LEVINE AM KAPLAN LD
Citation: Dj. Straus et al., PROGNOSTIC FACTORS IN THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NON-HODGKINS-LYMPHOMA - ANALYSIS OF AIDS CLINICAL-TRIALS GROUP PROTOCOL-142 - LOW-DOSE VERSUS STANDARD-DOSE M-BACOD PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, Journal of clinical oncology, 16(11), 1998, pp. 3601-3606

Authors: STRAUS DJ HUANG J TESTA MA LEVINE AM KAPLAN LD
Citation: Dj. Straus et al., PROGNOSTIC FACTORS IN THE TREATMENT OF HIV-ASSOCIATED NON-HODGKIN-LYMPHOMA (HANHL) - ANALYSIS OF ACTG-142 (LOW-DOSE VS STANDARD-DOSE MBACOD-CSF)(GM), Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 89-89

Authors: STRAUS DJ
Citation: Dj. Straus, INTRODUCTION - MULTIPLE-MYELOMA - CURRENT APPROACHES, Cancer investigation, 15(1), 1997, pp. 55-56

Authors: KAPLAN LD STRAUS DJ TESTA MA
Citation: Ld. Kaplan et al., CHEMOTHERAPY FOR AIDS-RELATED LYMPHOMAS - REPLY, The New England journal of medicine, 337(16), 1997, pp. 1173-1174

Authors: KAPLAN LD STRAUS DJ TESTA MA VONROENN J DEZUBE BJ COOLEY TP HERNDIER B NORTHFELT DW HUANG J TULPULE A LEVINE AM
Citation: Ld. Kaplan et al., LOW-DOSE COMPARED WITH STANDARD-DOSE M-BACOD CHEMOTHERAPY FOR NON-HODGKINS-LYMPHOMA ASSOCIATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The New England journal of medicine, 336(23), 1997, pp. 1641-1648

Authors: STRAUS DJ
Citation: Dj. Straus, HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED LYMPHOMAS, The Medical clinics of North America, 81(2), 1997, pp. 495

Authors: HEDRICK EE OBRIEN JP GLASSMAN J STRAUS DJ PORTLOCK CS SINGER A ZELENETZ AD MOSKOWITZ CH
Citation: Ee. Hedrick et al., PRIMARY MEDIASTINAL DIFFUSE LARGE-CELL LYMPHOMA (PMLCL) - CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS IN 93 PATIENTS, Blood, 90(10), 1997, pp. 345-345

Authors: MOSKOWITZ CH NIMER SD PORTLOCK CS STRAUS DJ PEARSE R OBRIEN JP BERGER M GARDNER S TRIPPETT TM ZELENETZ AD YAHALOM J
Citation: Ch. Moskowitz et al., IFOSFAMIDE (I), CARBOPLATIN (C) AND ETOPOSIDE (E) (ICE) CYTOREDUCTIONFOLLOWED BY HIGH-DOSE CHEMORADIOTHERAPY AND ASCT FOR REFRACTORY AND RELAPSED HODGKINS-DISEASE (HD) - AN INTENT TO TREAT STUDY, Blood, 90(10), 1997, pp. 1025-1025

Authors: STRAUS DJ
Citation: Dj. Straus, TREATMENT OF HODGKINS-DISEASE - THE ROLE OF RADIOTHERAPY AND OR CHEMOTHERAPY IN ADVANCED STAGES/, Bailliere's clinical haematology, 9(3), 1996, pp. 553-558

Authors: STRAUS DJ
Citation: Dj. Straus, TREATMENT OF BURKITTS-LYMPHOMA IN HIV-POSITIVE PATIENTS, Biomedicine & pharmacotherapy, 50(9), 1996, pp. 447-450

Authors: HIRSCH A VANDERELS N STRAUS DJ GOMEZ EG LEUNG D PORTLOCK CS YAHALOM J
Citation: A. Hirsch et al., EFFECT OF ABVD CHEMOTHERAPY WITH AND WITHOUT MANTLE OR MEDIASTINAL IRRADIATION ON PULMONARY-FUNCTION AND SYMPTOMS IN EARLY-STAGE HODGKINS-DISEASE, Journal of clinical oncology, 14(4), 1996, pp. 1297-1305

Authors: POPPELWELL LL FILIPPA D PORTLOCK CS STRAUS DJ YAHALOM J OBRIEN JP ZELENETZ AD MOSKOWITZ CH
Citation: Ll. Poppelwell et al., ANALYSIS OF TREATMENT STRATEGY AND SURVIVAL IN PATIENTS WITH LYMPHOCYTE PREDOMINANT HODGKINS-DISEASE, Blood, 88(10), 1996, pp. 355-355

Authors: FILIPPA DA LADANYI M WOLLNER N STRAUS DJ OBRIEN JP PORTLOCK C GANGI M SUN M
Citation: Da. Filippa et al., CD30 (KI-1)-POSITIVE MALIGNANT-LYMPHOMAS - CLINICAL, IMMUNOPHENOTYPIC, HISTOLOGIC, AND GENETIC-CHARACTERISTICS AND DIFFERENCES WITH HODGKINS-DISEASE, Blood, 87(7), 1996, pp. 2905-2917

Authors: STRAUS DJ
Citation: Dj. Straus, HIGH-RISK HODGKINS-DISEASE PROGNOSTIC FACTORS, Leukemia & lymphoma, 15, 1995, pp. 41-42

Authors: GAYNOR JJ FEUER EJ TAN CC WU DH LITTLE CR STRAUS DJ CLARKSON BD BRENNAN MF
Citation: Jj. Gaynor et al., ON THE USE OF CAUSE-SPECIFIC FAILURE AND CONDITIONAL FAILURE PROBABILITIES - EXAMPLES FROM CLINICAL ONCOLOGY DATA, Journal of the American Statistical Association, 88(422), 1993, pp. 400-409

Authors: YAHALOM J GULATI SC TOIA M MASLAK P MCCARRON EG OBRIEN JP PORTLOCK CS STRAUS DJ PHILLIPS J FUKS Z
Citation: J. Yahalom et al., ACCELERATED HYPERFRACTIONATED TOTAL-LYMPHOID IRRADIATION, HIGH-DOSE CHEMOTHERAPY, AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR REFRACTORYAND RELAPSING PATIENTS WITH HODGKINS-DISEASE, Journal of clinical oncology, 11(6), 1993, pp. 1062-1070

Authors: CZUCZMAN MS STRAUS DJ DIVGI CR GRAHAM M GARINCHESA P FINN R MYERS J OLD LJ LARSON SM SCHEINBERG DA
Citation: Ms. Czuczman et al., PHASE-I DOSE-ESCALATION TRIAL OF IODINE 131-LABELED MONOCLONAL-ANTIBODY OKB7 IN PATIENTS WITH NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 11(10), 1993, pp. 2021-2029
Risultati: 1-17 |